Why the big switch to Biogenerics? Read this report from the EMEA. It documents what can only be kindly described as INCOMPETENCE regarding the approval of iPlex for ANY indication. I have sincere doubts as to whether this company can survive with its current management ... maybe with ANY management. In my opinion, all this talk about Biogenerics is nothing more than a smokescreen. I have finally had it with Dr. Allan and company. Good luck to those left standing.
News 
Market Data 
Discover 
AI
